Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Int J Mol Sci ; 23(19)2022 Sep 30.
Article in English | MEDLINE | ID: mdl-36232877

ABSTRACT

Cellular memory is a controversial concept representing the ability of cells to "write and memorize" stressful experiences via epigenetic operators. The progressive course of chronic, non-communicable diseases such as type 2 diabetes mellitus, cancer, and arteriosclerosis, is likely driven through an abnormal epigenetic reprogramming, fostering the hypothesis of a cellular pathologic memory. Accordingly, cultured diabetic and cancer patient-derived cells recall behavioral traits as when in the donor's organism irrespective to culture time and conditions. Here, we analyze the data of studies conducted by our group and led by a cascade of hypothesis, in which we aimed to validate the hypothetical existence and transmissibility of a cellular pathologic memory in diabetes, arteriosclerotic peripheral arterial disease, and cancer. These experiments were based on the administration to otherwise healthy animals of cell-free filtrates prepared from human pathologic tissue samples representative of each disease condition. The administration of each pathologic tissue homogenate consistently induced the faithful recapitulation of: (1) Diabetic archetypical changes in cutaneous arterioles and nerves. (2) Non-thrombotic arteriosclerotic thickening, collagenous arterial encroachment, aberrant angiogenesis, and vascular remodeling. (3) Pre-malignant and malignant epithelial and mesenchymal tumors in different organs; all evocative of the donor's tissue histopathology and with no barriers for interspecies transmission. We hypothesize that homogenates contain pathologic tissue memory codes represented in soluble drivers that "infiltrate" host's animal cells, and ultimately impose their phenotypic signatures. The identification and validation of the actors in behind may pave the way for future therapies.


Subject(s)
Diabetes Mellitus, Type 2 , Peripheral Arterial Disease , Animals , Humans , Neovascularization, Pathologic
2.
Int J Mol Sci ; 23(3)2022 Jan 28.
Article in English | MEDLINE | ID: mdl-35163435

ABSTRACT

Lower-extremity arterial disease is a major health problem with increasing prevalence, often leading to non-traumatic amputation, disability and mortality. The molecular mechanisms underpinning abnormal vascular wall remodeling are not fully understood. We hypothesized on the existence of a vascular tissue memory that may be transmitted through soluble signaling messengers, transferred from humans to healthy recipient animals, and consequently drive the recapitulation of arterial wall thickening and other vascular pathologies. We examined the effects of the intralesional infiltration for 6 days of arteriosclerotic popliteal artery-derived homogenates (100 µg of protein) into rats' full-thickness wounds granulation tissue. Animals infiltrated with normal saline solution or healthy brachial arterial tissue homogenate obtained from traumatic amputation served as controls. The significant thickening of arteriolar walls was the constant outcome in two independent experiments for animals receiving arteriosclerotic tissue homogenates. This material induced other vascular morphological changes including an endothelial cell phenotypic reprogramming that mirrored the donor's vascular histopathology. The immunohistochemical expression pattern of relevant vascular markers appeared to match between the human tissue and the corresponding recipient rats. These changes occurred within days of administration, and with no cross-species limitation. The identification of these "vascular disease drivers" may pave novel research avenues for atherosclerosis pathobiology.


Subject(s)
Arteriosclerosis/metabolism , Granulation Tissue/metabolism , Popliteal Artery/injuries , Proteins/administration & dosage , Vascular System Injuries/chemically induced , Aged , Animals , Arteriosclerosis/pathology , Disease Models, Animal , Female , Humans , Male , Middle Aged , Rats , Vascular System Injuries/pathology
3.
Scars Burn Heal ; 8: 20595131211067380, 2022.
Article in English | MEDLINE | ID: mdl-35198238

ABSTRACT

BACKGROUND: Diabetic foot ulcers (DFU) are characterised by high levels of inflammatory mediators, resulting from sustained hyperglycaemic insult and the local microbial biofilm. The intralesional administration of epidermal growth factor (EGF) has emerged as an effective treatment that stimulates granulation and closure of DFU, reducing the risk of amputation. Within the wound, fibroblasts play key roles during the healing process, promoting granulation and contraction. The aim of the present study was to examine the anti-inflammatory effect of EGF in DFU-derived fibroblasts, challenged with lipopolysaccharide (LPS), under hyperglycaemic conditions, recreating in vitro what happens in a clinical scenario. METHODS: Healthy skin (HS) and DFU granulation tissue biopsies were used to isolate primary fibroblasts. The effect of LPS on cell proliferation was analysed. Transcriptional expression of toll-like receptor (TLR) pathway mediators (TLR4, TLR2, CD14, MYD88 and NFKB) and pro-inflammatory cytokines (TNF, IL-6 and IL-1B) were measured by semi-quantitative polymerase chain reaction (qPCR), in cells treated with appropriate concentrations of LPS, EGF and their combination. IL-6 protein concentration was quantified by ELISA. RESULTS: LPS stimulated proliferation of HS-derived fibroblasts, while inhibiting the proliferation of cells derived from DFU at the highest assayed concentration of 1 µg/mL. Regarding the TLR signalling pathway, LPS increased messenger RNA levels of mediators and pro-inflammatory genes, while EGF, alone or in the presence of LPS, downregulated them, except for IL-1B. CONCLUSION: The results suggest that EGF might elicit an anti-inflammatory response in LPS-challenged fibroblasts, even in a hyperglycaemic milieu. Collectively, our findings contribute to explain newly observed effects of EGF in the clinical arena. LAY SUMMARY: In this research article, we analyse the putative anti-inflammatory effect of epidermal growth factor (EGF) on fibroblast isolated from diabetic foot ulcer (DFU) granulation tissue. To induce the inflammatory response, the cells were treated with lipopolysaccharide (LPS), simulating the gram-negative bacterial infection that takes place in the wounds of diabetic patients. We studied the expression of genes involved in bacterial recognition receptors signalling pathway and those that code for different pro-inflammatory cytokines.We obtained primary fibroblasts from biopsies of a neuropathic diabetic ulcer and from healthy skin, the former was used as the control. Cells were isolated and grown in high glucose Dulbecco's Modified Eagle Medium (DMEM) culture medium, to simulate the hyperglycaemic insult. The effect of increasing concentrations of LPS on cell proliferation was analysed. Relative transcriptional expression of genes in the study was quantified by quantitative polymerase chain reaction (qPCR) in cells treated with LPS, EGF or a combination. Untreated cells served to normalise the expression.In the present study, we demonstrated that EGF modulated the primary immune response by reducing the activation of pathogen-recognition receptors and common genes involved in these signalling pathways, even in hyperglycaemic conditions. This effect translated in a decreased expression of pro-inflammatory cytokines. These results contribute to explain our previous observations about the reduction of circulating levels of inflammatory cytokines after local administration of human recombinant EGF in DFU. Further molecular studies should be carried out to fully understand the biological mechanisms elicited by EGF in this clinical scenario.

4.
MEDICC Rev ; 24(1): 44-58, 2022 01 31.
Article in English | MEDLINE | ID: mdl-34653116

ABSTRACT

BACKGROUND: Diabetic foot ulcers are a common diabetic complication leading to alarming figures of amputation, disability, and early mortality. The diabetic glucooxidative environment impairs the healing response, promoting the onset of a 'wound chronicity phenotype'. In 50% of ulcers, these non-healing wounds act as an open door for developing infections, a process facilitated by diabetic patients' dysimmunity. Infection can elicit biofilm formation that worsens wound prognosis. How this microorganism community is able to take advantage of underlying diabetic conditions and thrive both within the wound and the diabetic host is an expanding research field. OBJECTIVES: 1) Offer an overview of the major cellular and molecular derangements of the diabetic healing process versus physiological cascades in a non-diabetic host. 2) Describe the main immunopathological aspects of diabetics' immune response and explore how these contribute to wound infection susceptibility. 3) Conceptualize infection and biofilim in diabetic foot ulcers and analyze their dynamic interactions with wound bed cells and matrices, and their systemic effects at the organism level. 4) Offer an integrative conceptual framework of wound-dysimmunity-infection-organism damage. EVIDENCE AQUISITION: We retrieved 683 articles indexed in Medline/PubMed, SciELO, Bioline International and Google Scholar. 280 articles were selected for discussion under four major subheadings: 1) normal healing processes, 2) impaired healing processes in the diabetic population, 3) diabetic dysimmunity and 4) diabetic foot infection and its interaction with the host. DEVELOPMENT: The diabetic healing response is heterogeneous, torpid and asynchronous, leading to wound chronicity. The accumulation of senescent cells and a protracted inflammatory profile with a pro-catabolic balance hinder the proliferative response and delay re-epithelialization. Diabetes reduces the immune system's abilities to orchestrate an appropriate antimicrobial response and offers ideal conditions for microbiota establishment and biofilm formation. Biofilm-microbial entrenchment hinders antimicrobial therapy effectiveness, amplifies the host's pre-existing immunodepression, arrests the wound's proliferative phase, increases localized catabolism, prolongs pathogenic inflammation and perpetuates wound chronicity. In such circumstances the infected wound may act as a proinflammatory and pro-oxidant organ superimposed onto the host, which eventually intensifies peripheral insulin resistance and disrupts homeostasis. CONCLUSIONS: The number of lower-limb amputations remains high worldwide despite continued research efforts on diabetic foot ulcers. Identifying and manipulating the molecular drivers underlying diabetic wound healing failure, and dysimmunity-driven susceptibility to infection will offer more effective therapeutic tools for the diabetic population.


Subject(s)
Diabetes Mellitus , Diabetic Foot , Anti-Bacterial Agents/therapeutic use , Cuba , Diabetic Foot/drug therapy , Humans , Wound Healing
5.
Antibiotics (Basel) ; 10(11)2021 Nov 10.
Article in English | MEDLINE | ID: mdl-34827317

ABSTRACT

Often dismissed as a commensal, Mycoplasma hominis is an increasingly prominent target of research due to its role in septic arthritis and organ transplant failure in immunosuppressed patients, particularly lung transplantation. As a mollicute, its highly reductive genome and structure render it refractile to most forms of treatment and growing levels of resistance to the few sources of treatment left, such as fluoroquinolones. We examined antimicrobial susceptibility (AST) to fluoroquinolones on 72 isolates and observed resistance in three (4.1%), with corresponding mutations in the quinolone resistance-determining region (QRDR) of S83L or E87G in gyrA and S81I or E85V in parC. However, there were high levels of polymorphism identified between all isolates outside of the QRDR, indicating caution for a genomics-led approach for resistance screening, particularly as we observed a further two quinolone-susceptible isolates solely containing gyrA mutation S83L. However, both isolates spontaneously developed a second spontaneous E85K parC mutation and resistance following prolonged incubation in 4 mg/L levofloxacin for an extra 24-48 h. Continued AST surveillance and investigation is required to understand how gyrA QRDR mutations predispose M. hominis to rapid spontaneous mutation and fluoroquinolone resistance, absent from other susceptible isolates. The unusually high prevalence of polymorphisms in M. hominis also warrants increased genomics' surveillance.

6.
J Microbiol Methods ; 186: 106239, 2021 07.
Article in English | MEDLINE | ID: mdl-33991585

ABSTRACT

We used multi-locus variable-number of tandem repeat analysis (MLVA), p1, multi-locus sequence (MLS) and single nucleotide polymorphisms (SNP) typing to characterize a collection of Mycoplasma pneumoniae strains from Cuba and Germany. Among 67 strains, 5 p1, 7 MLVA, 11 MLS, and 11 SNP types were obtained.


Subject(s)
Bacterial Typing Techniques/methods , Multilocus Sequence Typing/methods , Mycoplasma pneumoniae/isolation & purification , Pneumonia, Mycoplasma/microbiology , Cuba , Genotype , Germany , Humans , Minisatellite Repeats , Mycoplasma pneumoniae/classification , Mycoplasma pneumoniae/genetics , Polymorphism, Single Nucleotide
7.
Front Endocrinol (Lausanne) ; 11: 560375, 2020.
Article in English | MEDLINE | ID: mdl-33224105

ABSTRACT

Insulin plays a major neuroprotective and trophic function for cerebral cell population, thus countering apoptosis, beta-amyloid toxicity, and oxidative stress; favoring neuronal survival; and enhancing memory and learning processes. Insulin resistance and impaired cerebral glucose metabolism are invariantly reported in Alzheimer's disease (AD) and other neurodegenerative processes. AD is a fatal neurodegenerative disorder in which progressive glucose hypometabolism parallels to cognitive impairment. Although AD may appear and progress in virtue of multifactorial nosogenic ingredients, multiple interperpetuative and interconnected vicious circles appear to drive disease pathophysiology. The disease is primarily a metabolic/energetic disorder in which amyloid accumulation may appear as a by-product of more proximal events, especially in the late-onset form. As a bridge between AD and type 2 diabetes, activation of c-Jun N-terminal kinase (JNK) pathway with the ensued serine phosphorylation of the insulin response substrate (IRS)-1/2 may be at the crossroads of insulin resistance and its subsequent dysmetabolic consequences. Central insulin axis bankruptcy translates in neuronal vulnerability and demise. As a link in the chain of pathogenic vicious circles, mitochondrial dysfunction, oxidative stress, and peripheral/central immune-inflammation are increasingly advocated as major pathology drivers. Pharmacological interventions addressed to preserve insulin axis physiology, mitochondrial biogenesis-integral functionality, and mitophagy of diseased organelles may attenuate the adjacent spillover of free radicals that further perpetuate mitochondrial damages and catalyze inflammation. Central and/or peripheral inflammation may account for a local flood of proinflammatory cytokines that along with astrogliosis amplify insulin resistance, mitochondrial dysfunction, and oxidative stress. All these elements are endogenous stressor, pro-senescent factors that contribute to JNK activation. Taken together, these evidences incite to identify novel multi-mechanistic approaches to succeed in ameliorating this pandemic affliction.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Brain/metabolism , Brain/pathology , Energy Metabolism/physiology , Insulin Resistance/physiology , Amyloid beta-Peptides/metabolism , Animals , Humans , Oxidative Stress/physiology
8.
Front Endocrinol (Lausanne) ; 11: 573032, 2020.
Article in English | MEDLINE | ID: mdl-33042026

ABSTRACT

Diabetes is constantly increasing at a rate that outpaces genetic variation and approaches to pandemic magnitude. Skin cells physiology and the cutaneous healing response are progressively undermined in diabetes which predisposes to lower limb ulceration, recidivism, and subsequent lower extremities amputation as a frightened complication. The molecular operators whereby diabetes reduces tissues resilience and hampers the repair mechanisms remain elusive. We have accrued the notion that diabetic environment embraces preconditioning factors that definitively propel premature cellular senescence, and that ulcer cells senescence impair the healing response. Hyperglycemia/oxidative stress/mitochondrial and DNA damage may act as major drivers sculpturing the senescent phenotype. We review here historical and recent evidences that substantiate the hypothesis that diabetic foot ulcers healing trajectory, is definitively impinged by a self-expanding and self-perpetuative senescent cells society that drives wound chronicity. This society may be fostered by a diabetic archetypal secretome that induces replicative senescence in dermal fibroblasts, endothelial cells, and keratinocytes. Mesenchymal stem cells are also susceptible to major diabetic senescence drivers, which accounts for the inability of these cells to appropriately assist in diabetics wound healing. Thus, the use of autologous stem cells has not translated in significant clinical outcomes. Novel and multifaceted therapeutic approaches are required to pharmacologically mitigate the diabetic cellular senescence operators and reduce the secondary multi-organs complications. The senescent cells society and its adjunctive secretome could be an ideal local target to manipulate diabetic ulcers and prevent wound chronification and acute recidivism. This futuristic goal demands harnessing the diabetic wound chronicity epigenomic signature.


Subject(s)
Cellular Senescence/physiology , Diabetic Foot/physiopathology , Wound Healing/physiology , DNA Damage , Humans , Mesenchymal Stem Cells/physiology , Oxidative Stress
9.
Peptides ; 126: 170269, 2020 04.
Article in English | MEDLINE | ID: mdl-32045621

ABSTRACT

The insulin signaling pathway plays a pivotal role in glucose metabolism and metabolic homeostasis. Disruption of this pathway is commonly seen in critical illness such as following severe burn injuries where homeostatic control is lost, leading to "insulin resistance" with poor blood glucose control. The aberrant signaling pathways involved in insulin resistance following burn injury include increases in hyperglycemic stress hormones, pro-inflammatory cytokines and free radical production. Leakage of mitochondrial sequestered self-antigens and signaling between mitochondria and endoplasmic reticulum also contribute to insulin resistance. Greater understanding of molecular processes involved in burn-related insulin resistance could potentially lead to the development of novel therapeutic approaches to improve patient management.


Subject(s)
Burns/metabolism , Hyperglycemia/metabolism , Hyperglycemia/pathology , Insulin Resistance , Mitochondria/pathology , Animals , Humans
10.
Int J Infect Dis ; 80: 115-117, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30634044

ABSTRACT

OBJECTIVES: Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in humans. Treatment of infections can be complicated by the occurrence of macrolide resistant strains. The study was conducted to evaluate the presence of resistant strains in Cuba and to determine the corresponding genotypes. METHODS: DNA of M. pneumoniae isolates and positive respiratory tract specimens collected in the years 2012 and 2017 were tested for resistance-associated mutations of 23S rRNA. In addition, strain types (P1 and MLVA) were determined. RESULTS: Macrolide resistance mutations were confirmed in 5 out of 27 strains (18.5%). Whereas both P1 subtypes 1 and 2 as well variants V2a and V2c were identified, only two MLVA types (4/5/7/2 and 3/5/6/2) could be found. CONCLUSIONS: During both sampling years, circulation of macrolide resistant strains was demonstrated. No association of resistance with a particular P1/MLVA type was found. Future longitudinal sampling to monitor prevalence of macrolide resistance of M. pneumoniae is recommended to verify the resistance pattern of this important pathogen of human respiratory tract infections.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Macrolides/pharmacology , Mycoplasma pneumoniae/isolation & purification , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Cuba , DNA, Bacterial/isolation & purification , Genotyping Techniques , Humans , Mycoplasma pneumoniae/drug effects , Pneumonia, Mycoplasma , RNA, Ribosomal, 23S/isolation & purification , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/microbiology , Specimen Handling
11.
BMC Infect Dis ; 18(1): 601, 2018 Nov 29.
Article in English | MEDLINE | ID: mdl-30486786

ABSTRACT

BACKGROUND: The increasing prevalence of macrolide resistant Mycoplasma genitalium is a major concern worldwide. In Cuba, several cases of clinical treatment failure with 1 g single dose and extended azithromycin regimen have been detected and the aim of the present investigation was to retrospectively determine the prevalence of macrolide-resistance mediating mutations (MRMM) in M. genitalium-positive samples conserved at the Cuban National Reference Laboratory of Mycoplasma Research between 2009 and 2016. METHODS: A total of 280 positive DNA extracts were analysed by a 5' nuclease assay for detection of M. genitalium MRMM. Ten urogenital specimens from patients with azithromycin treatment failure and MRMM were inoculated in Vero cell to obtain the isolates for subsequent determination of antimicrobial susceptibility. RESULTS: The overall prevalence of MRMM was 32%. No MRMM was detected in samples collected between 2009 and 2013 but since 2014 a dramatic increase to 90% (95% CI, 76-96%) in 2016 was seen. Three new M. genitalium isolates were isolated in Vero cell cultures and confirmed phenotypic resistance to macrolides in a cell-culture assisted susceptibility test. Preliminary observations suggest that combination therapy with levofloxacin and doxycycline may represent an affordable option for treatment of macrolide resistant M. genitalium infections. CONCLUSIONS: This investigation showed the rapid emergence and high prevalence of MRMM in M. genitalium-infected patients in Cuba and confirmed the phenotypic resistance in isolates carrying MRMM. We suggest that Cuban guidelines for sexually transmitted infections are modified to include testing for M. genitalium and detection of MRMM in patients with failure of syndromic treatment, to ensure that in these cases, the treatment will be guided by etiologic diagnosis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Macrolides/therapeutic use , Mycoplasma Infections/drug therapy , Mycoplasma Infections/epidemiology , Mycoplasma genitalium , Adult , Animals , Chlorocebus aethiops , Cuba/epidemiology , Diagnostic Errors/statistics & numerical data , Drug Resistance, Bacterial/drug effects , Female , Humans , Male , Microbial Sensitivity Tests , Mycoplasma Infections/microbiology , Mycoplasma genitalium/drug effects , Mycoplasma genitalium/genetics , Mycoplasma genitalium/isolation & purification , Prevalence , Retrospective Studies , Sexually Transmitted Diseases, Bacterial/drug therapy , Sexually Transmitted Diseases, Bacterial/epidemiology , Vero Cells
12.
J Clin Psychopharmacol ; 38(5): 454-459, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30106883

ABSTRACT

PURPOSE: The aim of this study was to assess the efficacy and safety of sertraline compared with placebo in a good clinical practice trial conducted with major depressive disorder patients naive to selective serotonin reuptake inhibitors. METHODS: This was a 10-week randomized, multicenter, placebo-controlled, double blind, superiority trial. Adult patients diagnosed with major depressive disorder (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria), total score of 19 to 36 in the 17-item Hamilton Depression Rating Scale (HAMD-17), were randomly allocated to sertraline (n = 39) or placebo (n = 38). Each patient received a fixed dose of sertraline 50 mg/d or placebo for 4 weeks. Afterward a flexible dose up to 200 mg/d was allowed if needed. The primary efficacy end point was clinical response defined as 50% score reduction in HAMD-17 at 10 weeks relative to baseline. Supplementary analysis was performed on HAMD-17 score change from baseline. FINDINGS: The clinical response favored sertraline (72% vs 32%; relative risk, 2.27; 95% confidence interval, 1.37-3.78; P = 0.0006). A linear mixed model showed arm × time interaction was significant (likelihood ratio test χ on 7 df = 48.42, P < 0.0001). The HAMD-17 change score favored sertraline from week 8 onwards. The most frequent adverse events in the sertraline arm were headache, diarrheas, and weight loss. IMPLICATIONS: In this trial, the benefit of sertraline compared with placebo appeared later than usual. The therapeutic process with a close doctor-patient relationship throughout the trial and the effect expectancy due to a new treatment might explain the response delay. TRIAL REGISTRATION: RPCEC, ID no. 00000128.


Subject(s)
Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/drug therapy , Selective Serotonin Reuptake Inhibitors/therapeutic use , Sertraline/therapeutic use , Adult , Depressive Disorder, Major/psychology , Double-Blind Method , Female , Humans , Male , Middle Aged , Treatment Outcome , Young Adult
13.
Int J STD AIDS ; 29(10): 994-998, 2018 09.
Article in English | MEDLINE | ID: mdl-29742999

ABSTRACT

Mycoplasma genitalium is an emerging sexually transmitted pathogen implicated in urethritis in men and several inflammatory reproductive tract syndromes in women. The prevalence of M. genitalium infections in Cuban patients with urogenital syndromes is unknown. The aim of this study was to analyse the prevalence of M. genitalium infection in sexually-active Cuban men and women with urogenital syndromes as a part of aetiological surveillance of urogenital syndromes in Cuba. Samples from men and women with urogenital syndromes submitted to the Mycoplasma Reference Laboratory for mycoplasma diagnosis from 1 January 2014 to 1 June 2015 were analysed by polymerase chain reaction (PCR) for detection of M. genitalium. A total of 971 samples were received and processed. Of the patients tested, 5.7% (47/824) of women and 27.9% (41/147) of men were positive for M. genitalium. This paper presents the largest study of M. genitalium infections among Cuban patients with urogenital syndromes and is Cuba's first M. genitalium survey. We suggest that M. genitalium should be considered in the Cuban sexually transmitted infection management protocols as an important pathogen, particularly in men.


Subject(s)
Mycoplasma Infections/diagnosis , Mycoplasma genitalium/isolation & purification , Mycoplasma genitalium/pathogenicity , Sexually Transmitted Diseases, Bacterial/microbiology , Urethritis/microbiology , Adult , Cuba/epidemiology , Female , Humans , Male , Mycoplasma Infections/epidemiology , Mycoplasma Infections/microbiology , Mycoplasma genitalium/genetics , Pelvic Inflammatory Disease/epidemiology , Pelvic Inflammatory Disease/microbiology , Polymerase Chain Reaction , Population Surveillance , Prevalence , Sexually Transmitted Diseases, Bacterial/epidemiology , Urethritis/diagnosis
14.
PLoS One ; 11(9): e0162924, 2016.
Article in English | MEDLINE | ID: mdl-27679992

ABSTRACT

Isolation of Mycoplasma genitalium from clinical specimens remains difficult and few strains are available for antimicrobial susceptibility testing. We describe the antimicrobial susceptibility of M. genitalium strains grown in Vero cell culture with first- and second- line antibiotics, using a modified cell-culture-based method. Macrolide- and -fluoroquinolone resistance determinants were detected by sequencing of the 23S and parC genes, respectively. Seven strains were examined, including three new, genetically distinct M. genitalium strains isolated from endocervical and urethral swab specimens from Cuban patients together with four reference strains isolated from specimens collected from men in Denmark, Sweden and Australia. Azithromycin was the most active drug against two of the Cuban M. genitalium strains with MICs values of 0.008 mg/liter, however, one strain was macrolide resistant with an MIC of >8 mg/liter, and the A2059G resistant genotype. Ciprofloxacin was the least active antimicrobial drug and moxifloxacin was the most active fluoroquinolone against the new clinical strains, although an MIC of 1 mg/l was found for two strains. However, no relevant parC mutations were detected. MICs for tetracyclines were 0.5-4 mg/liter. Although the number of Cuban strains was low, the results suggest that a single-dose azithromycin treatment could be ineffective, and that a second-line treatment with moxifloxacin, should become an option in Cuba. To our knowledge, this is the first report of isolation and antibiotic susceptibility testing of M. genitalium strains from the Latin-American region, and the first detection of macrolide resistance in such strains.

15.
Exp Parasitol ; 131(3): 393-8, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22584035

ABSTRACT

Trichomonas vaginalis can be naturally infected with intracellular Mycoplasma hominis. This bacterial infection may have implications for trichomonal virulence and disease pathogenesis. The objective of the study was to report the presence of M. hominis in Cuban T. vaginalis isolates and to describe the association between the phenotype M. hominis infected with RAPD genetic polymorphism of T. vaginalis. The Random Amplified Polymorphic DNA (RAPD) technique was used to determine genetic differences among 40 isolates of T. vaginalis using a panel of 30 random primers and these genetic data were correlated with the infection of isolates with M. hominis. The trees drawn based on RAPD data showed no relations with metronidazole susceptibility and significantly association with the presence of M. hominis (P=0.043), which demonstrates the existence of concordance between the genetic relatedness and the presence of M. hominis in T. vaginalis isolates. This result could point to a predisposition of T. vaginalis for the bacterial enters and/or survival.


Subject(s)
Mycoplasma hominis/isolation & purification , Polymorphism, Genetic , Trichomonas vaginalis/genetics , Trichomonas vaginalis/microbiology , Cuba , DNA, Bacterial/analysis , DNA, Bacterial/chemistry , Female , Humans , Multiplex Polymerase Chain Reaction , Mycoplasma hominis/genetics , Phylogeny , Random Amplified Polymorphic DNA Technique , Tenericutes/classification , Tenericutes/genetics , Tenericutes/isolation & purification , Urogenital System/microbiology , Urogenital System/parasitology
16.
Gac méd espirit ; 13(1)ene.-abr. 2011. tab
Article in Spanish | CUMED | ID: cum-45870

ABSTRACT

El glaucoma es un problema de salud y es la segunda causa de ceguera en el mundo después de la catarata. Durante las últimas décadas ha ocurrido un importante progreso en el arsenal terapéutico antiglaucomatoso. Si la presión intraocular no se controla con medicamentos, se procede a la intervención quirúrgica. Los daños sufridos por el nervio óptico son irreversibles para el mismo, y se sugiere operar antes que la afección haya avanzado demasiado. Objetivo: Describir los resultados de la trabeculectomía en los pacientes operados de glaucoma en la provincia de Sancti Spíritus en el año 2009. Metodología: Se realizó un estudio prospectivo, descriptivo. La población estuvo conformada por 72 pacientes glaucomatosos, realizando trabeculectomía en 78 ojos. Los datos se obtuvieron de las historias clínicas, se asumieron las variables edad, sexo, color de la piel, factores de riesgo, antecedentes patológicos personales generales, así como las complicaciones post-operatorias más frecuentes y tensión ocular postoperatoria. Resultados: La mayoría de los pacientes presentaron 61 años de edad y más, predominando el sexo masculino y el color de la piel no blanca. La hipertensión arterial fue la enfermedad general más frecuente y la hipertensión ocular el factor de riesgo fundamental. La complicación postoperatoria principal fue el hifema. Conclusiones: El hallazgo de la tensión ocular menor de 18 mmHg, en la mayoría de los operados después de la cirugía, infiere que el diagnóstico precoz y tratamiento oportuno del glaucoma es de vital importancia para prevenir la ceguera (AU)


Glaucoma is a health problem and is the second leading cause of blindness worldwide after cataract. During the last decades significant progress has been made in the antiglaucoma arsenal. If intraocular pressure is not controlled with medications, surgery is the second choice. Damage to the optic nerve is irreversible, and surgery is suggested before the condition has progressed too much. Objective: To describe the results of trabeculectomy in glaucoma patients operated in the province of Sancti Spiritus in 2009. Methodology: A prospective, descriptive study was made. The population consisted of 72 patients with glaucoma, by performing trabeculectomy in 78 eyes. The data were obtained from medical records. The variables chosen were age, sex, color of skin, risk factors, general personal medical history as well as more common post-operative complications and postoperative ocular pressure. Results: Most patients experienced 61 years of age and older, predominantly male, and skin color not white. Hypertension was the most frequent systemic disease and ocular hypertension major risk factor. The main postoperative complication was hyphaema. Conclusions: The finding of ocular pressure under 18 mmHg in most of the patients after surgery implies that early diagnosis and timely treatment of glaucoma is vital to prevent blindness (AU)


Subject(s)
Humans , Trabeculectomy , Hyphema , Glaucoma , Intraocular Pressure , Surgical Procedures, Operative , Intraoperative Complications
17.
J Matern Fetal Neonatal Med ; 24(1): 47-50, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20504068

ABSTRACT

OBJECTIVE: Ureaplasma urealyticum is one of the organisms most frequently isolated from the amniotic fluid of women with adverse pregnancy. The prevalence of U. urealyticum and U. parvum on samples of amniotic fluid from healthy asymptomatic pregnant women, and whether its detection is associated with P-PROM or preterm birth was investigated. METHODS: Transabdominal amniotic fluid obtained from 121 asymptomatic women at 16-20 weeks of gestation were tested for the detection of Ureaplasma spp., using a selective culture media. A Multiplex-Polymerase Chain Reaction (PCR) method was used for the identification of U. parvum and U. urealyticum. Pregnancy outcomes were obtained after the completion of all testing. RESULTS: Ureaplasma spp. was not identified by culture, but was identified by Multiplex-PCR in four subjects, two corresponding to U. parvum and two to U. urealyticum. The women positive to ureaplasmas had normal labor, and babies born from infected-ureaplasmas pregnant women had normal weight birth. Preterm birth with intact membranes was documented in four women, all negative to ureaplasmas, but associated with gestational hypertension, lost of liquids and low weight birth. CONCLUSIONS: Multiplex-PCR method was more sensitive that culture in detecting ureaplasma organism in amniotic fluid. No association of ureaplasmas with pregnancy outcomes was found.


Subject(s)
Amniotic Fluid/microbiology , Pregnancy Complications, Infectious/etiology , Ureaplasma Infections/complications , Ureaplasma urealyticum/isolation & purification , Female , Humans , Infant, Low Birth Weight , Infant, Newborn , Infant, Premature , Polymerase Chain Reaction , Pregnancy , Pregnancy Outcome
18.
Appl Environ Microbiol ; 74(5): 1639-41, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18192431

ABSTRACT

Biofilms can have deleterious effects on drinking water quality and may harbor pathogens. Experiments were conducted using 100 microg/liter silver to prevent biofilm formation in modified Robbins devices with polyvinyl chloride and stainless steel surfaces. No significant difference was observed on either surface between the silver treatment and the control.


Subject(s)
Biofilms/drug effects , Silver/toxicity , Water Purification/methods , Water Supply/standards , Biofilms/growth & development , Polyvinyl Chloride , Stainless Steel
19.
Article in English | MEDLINE | ID: mdl-17849299

ABSTRACT

This study was conducted to assess the efficacy of silver as a secondary disinfectant to replace or reduce the level of chlorine utilized in water distribution systems. Pseudomonas aeruginosa and Aeromonas hydrophila are opportunistic pathogens present in drinking water and have been associated with waterborne disease. After 8 hours of exposure to 100 microg/L of silver, there was a >6-log10 reduction in P. aeruginosa in tap water at room temperature at pH7 and a 5.55-log10 reduction in the presence of 3 mg/L humic acid. Similar reductions were observed at pH9. At 4 degrees C, reductions greater than 4-log10 were observed after 24 hours. For A. hydrophila, a >6-log10 reduction occurred at both pH7 and pH9 within nine hours. The World Health Organization has determined that this amount of silver could be used for water disinfection without health risks. Furthermore, silver shows promise as a secondary disinfectant, even in the presence of organic matter in concentrations that would reduce the effectiveness of free chlorine.


Subject(s)
Aeromonas hydrophila/drug effects , Disinfectants/pharmacology , Disinfection/methods , Pseudomonas aeruginosa/drug effects , Silver/pharmacology , Water Purification/methods , Aeromonas hydrophila/growth & development , Aeromonas hydrophila/isolation & purification , Colony Count, Microbial , Humic Substances , Hydrogen-Ion Concentration , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/isolation & purification , Water Pollutants/isolation & purification , Water Supply
20.
Rev Environ Contam Toxicol ; 191: 23-45, 2007.
Article in English | MEDLINE | ID: mdl-17708071

ABSTRACT

Silver has been used as an antimicrobial for thousands of years. Over the past several decades, it has been introduced into numerous new venues such as in the treatment of water, in dietary supplements, in medical applications, and to produce antimicrobial coatings and products. Silver is often used as an alternative disinfectant in applications in which the use of traditional disinfectants such as chlorine may result in the formation of toxic by-products or cause corrosion of surfaces. Silver has also been demonstrated to produce a synergistic effect in combination with several other disinfectants. Many mechanisms of the antibacterial effect of silver have been described, but its antiviral and antiprotozoal mechanisms are not well understood. Both microbial tolerance and resistance to silver have been reported; however, the effect of silver has been observed against a wide variety of microorganisms over a period of years. Further research is needed to determine the antimicrobial efficacy of silver in these new applications and the effects of its long-term usage.


Subject(s)
Anti-Infective Agents , Silver , Animals , Anti-Infective Agents/pharmacology , Drug Resistance, Bacterial , Food Contamination , Humans , Silver/pharmacology , Water Purification , Water Supply
SELECTION OF CITATIONS
SEARCH DETAIL
...